Quantum tunneling through vacuum-multiparticle induced potentials

The vacuum cavity mode induces a potential barrier and a well when an ultra-slow excited atom enters the interaction region so that it can be reflected or transmitted with a certain probability. We demonstrate here that a slow-velocity excited particle tunnels freely through a vacuum electromagnetic field mode filled with $N-1$ ground state atoms. The reason for this is the trapping of the moving atom into its upper state due to multiparticle influences and the corresponding decoupling from the interaction with the environment such that the emitter does not {\it see} the induced potentials.Comment: Multiparticle samples, quantum tunneling, vacuum induced potential

Photon scattering from strongly driven atomic ensembles

The second order correlation function for light emitted from a strongly and near-resonantly driven dilute cloud of atoms is discussed. Because of the strong driving, the fluorescence spectrum separates into distinct peaks, for which the spectral properties can be defined individually. It is shown that the second-order correlations for various combinations of photons from different spectral lines exhibit bunching together with super- or sub-Poissonian photon statistics, tunable by the choice of the detector positions. Additionally, a Cauchy-Schwarz inequality is violated for photons emitted from particular spectral bands. The emitted light intensity is proportional to the square of the number of particles, and thus can potentially be intense. Three different averaging procedures to model ensemble disorder are compared.Comment: 7 pages, 4 figure

Strong-field spatial interference in a tailored electromagnetic bath

Light scattered by a regular structure of atoms can exhibit interference signatures, similar to the classical double-slit. These first-order interferences, however, vanish for strong light intensities, restricting potential applications. Here, we show how to overcome these limitations to quantum interference in strong fields. First, we recover the first-order interference in strong fields via a tailored electromagnetic bath with a suitable frequency dependence. At strong driving, the optical properties for different spectral bands are distinct, thus extending the set of observables. We further show that for a two-photon detector as, e.g., in lithography, increasing the field intensity leads to twice the spatial resolution of the second-order interference pattern compared to the weak-field case.Comment: final versio

Measuring photon-photon interactions via photon detection

The strong non-linearity plays a significant role in physics, particularly, in designing novel quantum sources of light and matter as well as in quantum chemistry or quantum biology. In simple systems, the photon-photon interaction can be determined analytically. However, it becomes challenging to obtain it for more compex systems. Therefore, we show here how to measure strong non-linearities via allowing the sample to interact with a weakly pumped quantized leaking optical mode. We found that the detected mean-photon number versus pump-field frequency shows several peaks. Interestingly, the interval between neighbour peaks equals the photon-photon interaction potential. Furthermore, the system exhibits sub-Poissonian photon statistics, entanglement and photon switching with less than one photon. Finally, we connect our study with existing related experiments.Comment: 4 pages, 3 figure

Flexible generation of correlated photon pairs in different frequency ranges

The feasibility to generate correlated photon pairs at variable frequencies is investigated. For this purpose, we consider the interaction of an off-resonant laser field with a two-level system possessing broken inversion symmetry. We show that the system generates non-classical photon pairs exhibiting strong intensity-intensity correlations. The intensity of the applied laser tunes the degree of correlation while the detuning controls the frequency of one of the photons which can be in the THz-domain. Furthermore, we observe the violation of a Cauchy-Schwarz inequality characterizing these photons.Comment: 5 pages, 4 figure

Temporal variability in the nutrient biogeochemistry of the surface North Atlantic: 15 years of ship of opportunity data

Ocean biological processes play an important role in the global carbon cycle via the production of organic matter and its subsequent export. Often, this flux is assumed to be in steady state; however, it is dependent on nutrients introduced to surface waters via multiple mechanisms, some of which are likely to exhibit both intra‐annual and interannual variability leading to comparable variability in ocean carbon uptake. Here we test this variability using surface (5 m) inorganic nutrient concentrations from voluntary observing ships and satellite‐derived estimates of chlorophyll and net primary production. At lower latitudes, the seasonality is small, and the monthly averages of nitrate:phosphate are lower than the canonical 16:1 Redfield ratio, implying nitrogen limitation, a situation confirmed via a series of nutrient limitation experiments conducted between Bermuda and Puerto Rico. The nutrient seasonal cycle is more pronounced at higher latitudes, with clear interannual variability. Over a large area of the midlatitude North Atlantic, the winters of 2009/2010 and 2010/2011 had nitrate values more than 1μmol L−1 higher than the 2002–2017 average, suggesting that during this period, the system may have shifted to phosphorus limitation. This nitrate increase meant that, in the region between 31° and 39° N, new production calculated from nitrate uptake was 20.5g C m−2 in 2010, more than four times higher than the median value of the whole observing period. Overall, we suggest that substantial variability in nutrient concentrations and biological carbon uptake occurs in the North Atlantic with interannual variability apparent over a number of different time scales

Independent and complementary bio-functional effects of CuO and Ga2O3 incorporated as therapeutic agents in silica- and phosphate-based bioactive glasses

The incorporation of therapeutic-capable ions into bioactive glasses (BGs), either based on silica (SBGs) or phosphate (PBGs), is currently envisaged as a proficient path for facilitating bone regeneration. In conjunction with this view, the single and complementary structural and bio-functional roles of CuO and Ga2O3 (in the 2–5 mol% range) were assessed, by deriving a series of SBG and PBG formulations starting from the parent glass systems, FastOs®BG – 38.5SiO2—36.1CaO—5.6P2O5—19.2MgO—0.6CaF2, and 50.0P2O5—35.0CaO—10.0Na2O—5.0 Fe2O3 (mol%), respectively, using the process of melt-quenching. The inter-linked physico-chemistry – biological response of BGs was assessed in search of bio-functional triggers. Further light was shed on the structural role – as network former or modifier – of Cu and Ga, immersed in SBG and PBG matrices. The preliminary biological performance was surveyed in vitro by quantification of Cu and Ga ion release under homeostatic conditions, cytocompatibility assays (in fibroblast cell cultures) and antibacterial tests (against Staphylococcus aureus). The similar (Cu) and dissimilar (Ga) structural roles in the SBG and PBG vitreous networks governed their release. Namely, Cu ions were leached in similar concentrations (ranging from 10–35 ppm and 50–110 ppm at BG doses of 5 and 50 mg/mL, respectively) for both type of BGs, while the release of Ga ions was 1–2 orders of magnitude lower in the case of SBGs (i.e., 0.2–6 ppm) compared to PBGs (i.e., 9–135 ppm). This was attributed to the network modifier role of Cu in both types of BGs, and conversely, to the network former (SBGs) and network modifier (PBGs) roles of Ga. All glasses were cytocompatible at a dose of 5 mg/mL, while at the same concentration the antimicrobial efficiency was found to be accentuated by the coupled release of Cu and Ga ions from SBG. By collective assessment, the most prominent candidate material for the further development of implant coatings and bone graft substitutes was delineated as the 38.5SiO2—34.1CaO—5.6P2O5—16.2MgO—0.6CaF2—2.0CuO—3.0Ga2O3 (mol%) SBG system, which yielded moderate Cu and Ga ion release, excellent cytocompatibility and marked antibacterial efficacy.publishe

Activation of ERAD Pathway by Human Hepatitis B Virus Modulates Viral and Subviral Particle Production

Hepatitis B virus (HBV) belongs to the Hepadnaviridae family of enveloped DNA viruses. It was previously shown that HBV can induce endoplasmic reticulum (ER) stress and activate the IRE1-XBP1 pathway of the unfolded protein response (UPR), through the expression of the viral regulatory protein X (HBx). However, it remained obscure whether or not this activation had any functional consequences on the target genes of the UPR pathway. Of these targets, the ER degradation-enhancing, mannosidase-like proteins (EDEMs) are thought to play an important role in relieving the ER stress during UPR, by recognizing terminally misfolded glycoproteins and delivering them to the ER-associated degradation (ERAD). In this study, we investigated the role of EDEMs in the HBV life-cycle. We found that synthesis of EDEMs (EDEM1 and its homologues, EDEM2 and EDEM3) is significantly up-regulated in cells with persistent or transient HBV replication. Co-expression of the wild-type HBV envelope proteins with EDEM1 resulted in their massive degradation, a process reversed by EDEM1 silencing. Surprisingly, the autophagy/lysosomes, rather than the proteasome were involved in disposal of the HBV envelope proteins. Importantly, inhibition of the endogenous EDEM1 expression in HBV replicating cells significantly increased secretion of both, enveloped virus and subviral particles. This is the first report showing that HBV activates the ERAD pathway, which, in turn, reduces the amount of envelope proteins, possibly as a mechanism to control the level of virus particles in infected cells and facilitate the establishment of chronic infections

a pilot study, 2013

Introduction After recognition of European outbreaks of Clostridium difficile infections (CDIs) associated with the emergence of PCR ribotype 027/NAP1 in 2005, CDI surveillance at country level was encouraged by the European Centre for Disease Prevention and Control (ECDC) [1]. In 2008, an ECDC-supported European CDI survey (ECDIS) identified large intercountry variations in incidence rates and distribution of prevalent PCR ribotypes, with the outbreak-related PCR ribotype 027 being detected in 5% (range: 0–26) of the characterised isolates [2]. The surveillance period was limited to one month and the representation of European hospitals was incomplete; however, this has been the only European (comprising European Union (EU)/European Economic Area (EEA) and EU candidate countries) CDI surveillance study. The authors highlighted the need for national and European surveillance to control CDI. Yet, European countries were found to have limited capacity for diagnostic testing, particularly in terms of standard use of optimal methods and absence of surveillance protocols and a fully validated, standardised and exchangeable typing system for surveillance and/or outbreak investigation. As of 2011, 14 European countries had implemented national CDI surveillance, with various methodologies [3]. National surveillance systems have since reported a decrease in CDI incidence rate and/or prevalence of PCR ribotype 027 in some European countries [4-8]. However, CDI generally remains poorly controlled in Europe [9], and PCR ribotype 027 continues to spread in eastern Europe [10-12] and globally [13]. In 2010, ECDC launched a new project, the European C. difficile Infection Surveillance Network (ECDIS-Net), to enhance surveillance of CDI and laboratory capacity to test for CDI in Europe. The goal of ECDIS- Net was to establish a standardised CDI surveillance protocol suitable for application all over Europe in order to: (i) estimate the incidence rate and total infection rate of CDI (including recurrent CDI cases) in European acute care hospitals; (ii) provide participating hospitals with a standardised tool to measure and compare their own incidence rates with those observed in other participating hospitals; (iii) assess adverse outcomes of CDI such as complications and death; and (iv) describe the epidemiology of CDI concerning antibiotic susceptibility, PCR ribotypes, presence of tcdA, tcdB and binary toxins and detect new emerging types at local, national and European level. The primary objectives of the present study were to: (i) test the pilot protocol for the surveillance of CDI in European acute care hospitals developed by ECDIS-Net (methodology, variables and indicators); (ii) assess the feasibility and workload of collecting the required hospital data, case- based epidemiological and microbiological data; and (iii) evaluate the quality of data collected, whether in the presence or absence of existing national CDI surveillance activities. A secondary aim was to assess the relationship between patient and microbiological characteristics and in-hospital outcome of CDI to confirm the added value of collecting detailed epidemiological and microbiological data on CDI at European level